25% off all training courses Offer ends May 29, 2026
View HIPAA Courses
25% off all training courses
View HIPAA Courses
Offer ends May 29, 2026

The HIPAA Journal is the leading provider of HIPAA training, news, regulatory updates, and independent compliance advice.

FDA Issues Recall Notice for GE HealthCare Centricity Universal Viewer

A class 2 recall has been issued by the U.S. Food and Drug Administration (FDA) for certain GE HealthCare Centricity medical imaging products due to a vulnerability that could potentially be exploited by an unauthorized individual to manipulate data or impact system availability. Centricity Universal Viewer is a device that displays medical images such as mammograms and data from various imaging sources. The vulnerability affects the following Centricity Universal Viewer software versions:

  • Versions 5.0 SP6 through UV 5.0 SP7.1
  • Versions 6.0 through 6.0 Sp10.4.1
  • Versions 7.0 through 7.0 Sp2.0.1

The recall was issued as the vulnerability may cause temporary or medically reversible adverse health consequences, but where the probability of serious adverse health consequences is remote. The vulnerability is due to user login credentials being exposed on the local client workstation. As such, an unauthorized individual could obtain the credentials and potentially impact system availability and/or manipulate data; however, the potential for exploitation is limited, as direct physical access to the local workstation is required.

“Patient safety is our top priority. There have been no reports of unauthorized access to patient data as a result of this potential issue. Direct physical access to the workstation is necessary to exploit this potential vulnerability,” a GE HealthCare spokesperson told The HIPAA Journal. The vulnerability was discovered by GE Healthcare during routine testing, and the company is working on a permanent fix. GE HealthCare has issued instructions for customers to follow to allow them to continue using their devices until the fix is issued.

According to the FDA’s recall notice, in order to continue using the affected products, users must ensure that appropriate security controls are implemented, as stated in the product manuals. Network account authentication should be implemented by using Active Directory/LDAP services for user management. If network authentication is not possible, users should contact GE Healthcare to request temporary steps to mitigate the issue.

Get The FREE
HIPAA Compliance Checklist

Immediate Delivery of Checklist Link To Your Email Address

Please Enter Correct Email Address

Your Privacy Respected

HIPAA Journal Privacy Policy

 

Author: Steve Alder is the editor-in-chief of The HIPAA Journal. Steve is responsible for editorial policy regarding the topics covered in The HIPAA Journal. He is a specialist on healthcare industry legal and regulatory affairs, and has 10 years of experience writing about HIPAA and other related legal topics. Steve has developed a deep understanding of regulatory issues surrounding the use of information technology in the healthcare industry and has written hundreds of articles on HIPAA-related topics. Steve shapes the editorial policy of The HIPAA Journal, ensuring its comprehensive coverage of critical topics. Steve Alder is considered an authority in the healthcare industry on HIPAA. The HIPAA Journal has evolved into the leading independent authority on HIPAA under Steve’s editorial leadership. Steve manages a team of writers and is responsible for the factual and legal accuracy of all content published on The HIPAA Journal. Steve holds a Bachelor’s of Science degree from the University of Liverpool. You can connect with Steve via LinkedIn or email via stevealder(at)hipaajournal.com

x

Is Your Organization HIPAA Compliant?

Find Out With Our Free HIPAA Compliance Checklist

Get Free Checklist